The Peptide Agonist NG29 Induces Effective Transvascular Delivery Across the BTB of Malignant Glioma and the Accumulation of Two Different-sized Contrast Agents via B1R and a COX-dependent Pathway. Here, BDKRB1 is linked to malignant glioma.